OVEREXPRESSION OF P53 TUMOR-SUPPRESSOR PROTEIN IN POROKERATOSIS

被引:69
|
作者
MAGEE, JW
MCCALMONT, TH
LEBOIT, PE
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT DERMATOL,SAN FRANCISCO,CA 94143
关键词
D O I
10.1001/archderm.130.2.187
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: p53 is a tumor suppressor nucleoprotein. Mutations of the p53 gene have been found in a variety of malignant neoplasms. Wild-type p53 has a short half-life, possibly only 20 to 30 minutes, and is not present in the nucleus at levels that are detectable with routine immunohistochemical techniques. Mutant p53 has a longer half-life, and is readily detectable with immunoperoxidase staining. Results: We studied 17 specimens from patients with either porokeratosis of Mibelli or actinic porokeratosis, using immunoperoxidase staining with an antibody directed against the p53. There was staining of lesional keratinocyte nuclei in 16 of 17 specimens, limited in most cases to the zone between carnoid lamellae. Staining for proliferating cell nuclear antigen was increased above background levels in only six of 13 specimens. Conclusions: The finding of p53 immunoperoxidase staining in porokeratosis suggests genetic mutation, as occurs in other cutaneous keratinocytic neoplasms, and the lack of corresponding proliferating cell nuclear antigen expression in many specimens indicates that p53 overexpression is not simply a reflection of increased cellular proliferation.
引用
收藏
页码:187 / 190
页数:4
相关论文
共 50 条
  • [31] Involvement of the p53 tumor-suppressor protein in the development of antinociceptive tolerance to morphine
    Tan-No, Koichi
    Shimoda, Masakazu
    Watanabe, Kenya
    Nakagawasai, Osamu
    Niijima, Fukie
    Kanno, Syu-ichi
    Ishikawa, Masaaki
    Bakalkin, Georgy
    Tadano, Takeshi
    NEUROSCIENCE LETTERS, 2009, 450 (03) : 365 - 368
  • [32] Unique complex between bacterial azurin and tumor-suppressor protein p53
    Apiyo, D
    Wittung-Stafshede, P
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 332 (04) : 965 - 968
  • [33] CYCLIN-G IS A TRANSCRIPTIONAL TARGET OF THE P53 TUMOR-SUPPRESSOR PROTEIN
    OKAMOTO, K
    BEACH, D
    EMBO JOURNAL, 1994, 13 (20): : 4816 - 4822
  • [34] Structural studies on the tumor-suppressor protein p53 and its interaction with DNA
    Shakked, Zippi
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2007, 24 (06): : 643 - 643
  • [35] MUTATION AND OVEREXPRESSION OF THE P53 TUMOR-SUPPRESSOR GENE FREQUENTLY OCCURS IN UTERINE AND OVARIAN SARCOMAS
    LIU, FS
    KOHLER, MF
    MARKS, JR
    BAST, RC
    BOYD, J
    BERCHUCK, A
    OBSTETRICS AND GYNECOLOGY, 1994, 83 (01): : 118 - 124
  • [36] ASSOCIATION OF IMMUNOHISTOCHEMICAL P53 TUMOR-SUPPRESSOR GENE PROTEIN OVEREXPRESSION WITH PROGNOSIS IN HIGHLY PROLIFERATIVE HUMAN MAMMARY ADENOCARCINOMAS
    SCHIMMELPENNING, H
    ERIKSSON, ET
    ZETTERBERG, A
    AUER, GU
    WORLD JOURNAL OF SURGERY, 1994, 18 (06) : 827 - 833
  • [37] Overexpression of p53 tumor suppressor gene in pterygia
    Weinstein, O
    Rosenthal, G
    Zirkin, H
    Monos, T
    Lifshitz, T
    Argov, S
    EYE, 2002, 16 (05) : 619 - 621
  • [38] IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE IN CLINICAL ONCOLOGY
    CHANG, FJ
    SYRJANEN, S
    SYRJANEN, K
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) : 1009 - 1022
  • [39] Overexpression of p53 tumor suppressor gene in pterygia
    O Weinstein
    G Rosenthal
    H Zirkin
    T Monos
    T Lifshitz
    S Argov
    Eye, 2002, 16 : 619 - 621
  • [40] THE P53 TUMOR-SUPPRESSOR GENE IN BREAST-CANCER
    ELLEDGE, RM
    ALLRED, DC
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (01) : 39 - 47